Abstract
INTERACTIONS of CD4 with the class II major histocompatibility complex (MHC) are crucial during thymic ontogeny1 and subsequently for helper and cytotoxic functions of CD4+CD8− T lymphocytes2–5. CD4 is the receptor for the T-lymphotropic human immunodeficiency virus and binds its envelope glycoprotein, gp1206–10. The residues involved in gp120 binding have been localized to a region within the immunoglobulin-like domain I of CD4, which corresponds to CDR2 of an immunoglobulin variable region11–13, but the CD4 residues important in MHC class II interaction have not been characterized. Here, using a cell-binding assay dependent specifically on the CD4–MHC class II association, we analyse the effects of mutations in CD4 on class II versus gp120 binding. Mutations in CDR2 that destroy gp120 binding affect CD4–MHC class II binding similarly. In addition, binding of soluble gp120 to CD4–transfected cells abrogates their ability to interact with class II-bearing B lymphocytes. In contrast, other mutations within domains I or II that have no effect on gp120 binding eliminate or substantially decrease class II interaction. Thus, the CD4 binding site for class II MHC is more complex than the gp120 binding site, possibly reflecting a broader area of contact with the former ligand and a requirement for appropriate juxtaposition of the two N-terminal domains. The ability of gp120 to inhibit the binding of class II MHC to CD4 could be important in disrupting normal T-cell physiology, acting both to inhibit immune responses and to prevent differentiation of CD4+CD8+ thymocytes into CD4+CD8− T lymphocytes.
Similar content being viewed by others
Article PDF
References
Kruisbeek, A. M. et al. J. exp. Med. 161, 1029–1047 (1985).
Krensky, A. M., Reiss, C. S., Mier, J. W., Strominger, J. L. & Burakoff, S. J. Proc. natn. Acad. Sci. U.S.A. 79, 2365–2369 (1982).
Meuer, S. C., Schlossman, S. F. & Reinherz, E. L. Proc. natn. Acad. Sci. U.S.A. 79, 4395–4399 (1982).
Biddison, W., Rao, P., Talle, M. A., Goldstein, G. & Shaw, S. J. J. exp. Med. 156, 1065–1076 (1982).
Marrack, P. et al. J. exp. Med. 158, 1077–1091 (1983).
Klatzmann, D. et al. Science 225, 59–63 (1984).
Dalgleish, A. G. et al. Nature 312, 763–766 (1984).
Sattentau, Q., Dalgleish, A., Weiss, R. & Beverley, P. C. L. Science 234, 1120–1123 (1986).
McDougal, J. S. et al. Science 231, 382–385 (1986).
Maddon, P. J. et al. Cell 47, 333–348 (1986).
Peterson, A. & Seed, B. Cell 54, 65–72 (1988).
Landau, N. R., Warton, M. & Littman, D. R. Nature 334, 159–162 (1988).
Clayton, L. K. et al. Nature 335, 363–366 (1988).
Doyle, C. & Strominger, J. L. Nature 330, 256–259 (1987).
Eichmann, K., Jonsson, J. I., Falk, I. & Emmrich, F. Eur. J. Immun. 17, 643–650 (1987).
Rudd, C. E., Trevillyan, J. M., Dasgupta, J. D., Wong, L. L. & Schlossman, S. F. Proc. natn. Acad. Sci. U.S.A. 85, 5190–5194 (1988).
Veillette, A., Bookman, M. A., Horak, E. M. & Bolen, J. B. Cell 55, 301–308 (1988).
Mellins, E., Woelfel, M. & Pious, D. Hum. Immun. 18, 211–223 (1987).
Gay, D., Buus, S., Pasternak, J., Kappler, J. & Marrack, P. Proc. natn. Acad. Sci. U.S.A. 85, 5629–5633 (1988).
Maddon, P. J. et al. Proc. natn. Acad. Sci. U.S.A. 84, 9155–9159 (1987).
Epp, O., Lattman, E. E., Schiffer, M., Huber, R. & Palm, W. Biochemistry 14, 4943–4952 (1975).
Richardson, N. E. et al. Proc. natn. Acad. Sci. U.S.A. 85, 6102–6106 (1988).
Hussey, R. E. et al. Nature 331, 78–81 (1988).
Lasky, L. et al. Cell 50, 975–985 (1987).
Meuer, S. C. et al. Nature 303, 808–810 (1983).
Schneider, I., Kaaden, O., Copeland, J. D., Oroslan, S. & Hunsmann, G. J. gen. Virol. 67, 2533–2539 (1986).
Samasundaran, M. & Robinson, H. L. J. Virol. 61, 3114–3119 (1987).
Sodroski, J., Goh, W. C., Rosen, C., Campbell, K. & Haseltine, W. A. Nature 322, 470–474 (1986).
Lifson, J. et al. Nature 323, 725–728 (1986).
Siliciano, R. F. et al. Cell 54, 561–575 (1988).
Diamond, D. C. et al. J. Immun. 141, 3715–3717 (1988).
Weinhold, K. J. et al. J. Immun. (in the press).
Seed, B. & Aruffo, A. Proc. natn. Acad. Sci. U.S.A. 84, 3365–3369 (1987).
Pesando, J. M. & Graf, L. J. Immun 136, 4311–4318 (1986).
Lampson, L. A. & Levy, R. J. Immun. 125, 293–299 (1980).
Levine, F. et al. Proc. natn. Acad. Sci. U.S.A. 82, 3741–3745 (1985).
Levine, F., Erlich, H., Mach, B. & Pious, D. J. Immun. 134, 637–640 (1985).
Pious, D., Dickson, L., Levine, F., Cotner, T. & Johnson, R. J. J. exp. Med. 162, 1193–1207 (1985).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Clayton, L., Sieh, M., Pious, D. et al. Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding. Nature 339, 548–551 (1989). https://doi.org/10.1038/339548a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/339548a0
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.